Sanofi-aventis net up by 3.2%, sales down by 1.7 %
Sanofi-aventis, the world's third largest pharma company with sales of Euro 27.6 billion, has managed to improve its bottom line despite lower sales during the year ended December 2008. The company's net profit improved by 3.2 per cent to Euro 7,186 million from Euro 6,961 million in the previous year. Its net sales declined by 1.7 per cent to Euro 27,568 million from Euro 28,052 million. The earning per share improved to Euro 5.49 from Euro 5.17 in the previous year.